Lenci I - Search Results

1

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C.

Di Maio VC, Barbaliscia S, Teti E, Fiorentino G, Milana M, Paolucci S, Pollicino T, Morsica G, Starace M, Bruzzone B, Gennari W, Micheli V, Yu La Rosa K, Foroghi L, Calvaruso V, Lenci I, Polilli E, Babudieri S, Aghemo A, Raimondo G, Sarmati L, Coppola N, Pasquazzi C, Baldanti F, Parruti G, Perno CF, Angelico M, Craxì A, Andreoni M, Ceccherini-Silberstein F; HCV Virology Italian Resistance Network Group (Vironet C). Di Maio VC, et al. Among authors: lenci i. Liver Int. 2021 Aug;41(8):1802-1814. doi: 10.1111/liv.14797. Epub 2021 Feb 8. Liver Int. 2021. PMID: 33497016

2

Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.

Di Paolo D, Tisone G, Piccolo P, Lenci I, Zazza S, Angelico M. Di Paolo D, et al. Among authors: lenci i. Transplantation. 2004 Apr 27;77(8):1203-8. doi: 10.1097/01.tp.0000118904.63669.eb. Transplantation. 2004. PMID: 15114086

3

A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.

Angelico M, Petrolati A, Lionetti R, Lenci I, Burra P, Donato MF, Merli M, Strazzabosco M, Tisone G. Angelico M, et al. Among authors: lenci i. J Hepatol. 2007 Jun;46(6):1009-17. doi: 10.1016/j.jhep.2006.12.017. Epub 2007 Feb 5. J Hepatol. 2007. PMID: 17328985 Clinical Trial.

4

Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment.

Lenci I, Angelico M, Tisone G, Orlacchio A, Palmieri G, Pinci M, Bombardieri R, Curatolo P. Lenci I, et al. J Hepatol. 2008 Jun;48(6):1026-9. doi: 10.1016/j.jhep.2008.01.036. Epub 2008 Mar 31. J Hepatol. 2008. PMID: 18436329 Free article.

5

Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression.

Lionetti R, Tisone G, Palmieri G, Almerighi C, Anselmo A, Tariciotti L, Lenci I, De Luca L, Monaco A, Angelico M. Lionetti R, et al. Among authors: lenci i. Dig Liver Dis. 2010 Apr;42(4):297-303. doi: 10.1016/j.dld.2009.08.008. Epub 2009 Oct 8. Dig Liver Dis. 2010. PMID: 19818696

6

Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!".

Baiocchi L, Lenci I, Carbone M, Angelico M. Baiocchi L, et al. Among authors: lenci i. Hepatology. 2009 Nov;50(5):1676-7. doi: 10.1002/hep.23218. Hepatology. 2009. PMID: 19876945 No abstract available.

7

Patterns of chronic hepatitis B in Central Italy: a cross-sectional study.

Piccolo P, Lenci I, Telesca C, Di Paolo D, Bandiera F, De Melia L, Sorbello O, Renier G, Ricci GL, Nosotti L, Romano M, De Santis A, Levrero M, Antonucci G, Longo MA, Annicchiarico BE, Angelico M; Hep B Free Network Investigators. Piccolo P, et al. Among authors: lenci i. Eur J Public Health. 2010 Dec;20(6):711-3. doi: 10.1093/eurpub/ckp168. Epub 2009 Nov 2. Eur J Public Health. 2010. PMID: 19884157

8

A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.

Piccolo P, Lenci I, Demelia L, Bandiera F, Piras MR, Antonucci G, Nosotti L, Mari T, De Santis A, Ponti ML, Sorbello O, Iacomi F, Angelico M. Piccolo P, et al. Among authors: lenci i. Antivir Ther. 2009;14(8):1165-74. doi: 10.3851/IMP1466. Antivir Ther. 2009. PMID: 20032546 Clinical Trial.

9

Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis.

Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L, Ciotti M, Guenci T, Perno CF, Angelico M. Lenci I, et al. Dig Liver Dis. 2010 Aug;42(8):578-84. doi: 10.1016/j.dld.2009.12.003. Epub 2010 Jan 22. Dig Liver Dis. 2010. PMID: 20097143

10

One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis.

Di Paolo D, Lenci I, Cerocchi C, Tariciotti L, Monaco A, Brega A, Lotti L, Tisone G, Angelico M. Di Paolo D, et al. Among authors: lenci i. Transpl Int. 2010 Nov;23(11):1105-12. doi: 10.1111/j.1432-2277.2010.01104.x. Epub 2010 Aug 19. Transpl Int. 2010. PMID: 20492620 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page